Upload
myza-templanza-oraa
View
219
Download
0
Embed Size (px)
Citation preview
8/8/2019 Inflammation & Immunity Final Final Final (7)
1/53
Group 2
8/8/2019 Inflammation & Immunity Final Final Final (7)
2/53
Immunologyy Is the study of the immune system and immune
responses
y Immune responses involve complex interactionsamong many different types of body cells and cellularsecretions.
8/8/2019 Inflammation & Immunity Final Final Final (7)
3/53
Immune System
y The third line of defense against pathogens; a specifichost defense mechanism
y It involve the production of antibodies that recognize,bind to and inactivate or destroyspecific pathogens ortheir toxins
8/8/2019 Inflammation & Immunity Final Final Final (7)
4/53
Immunity
y Is the condition of being immune or resistant to aparticular infectious disease.
y Is a biological term that describes a state of havingsufficient biological defenses toavoid infection, disease, or other unwanted biologicalinvasion.
8/8/2019 Inflammation & Immunity Final Final Final (7)
5/53
Types of Immunity
8/8/2019 Inflammation & Immunity Final Final Final (7)
6/53
Types of Immunity
Natural (Innate) Immunity
y Nonspecific immunity present at birth
y Provides a nonspecific response to any foreign invader,regardless of the invaders composition
y The basis of natural defense mechanism is the abilityto distinguish between foe or self or nonself
y Natural mechanisms include physical and chemicalbarriers, the action of WBCs and inflammationresponse.
8/8/2019 Inflammation & Immunity Final Final Final (7)
7/53
Acquired (Adaptive) Immunity
y Immunity develop after birth
y Immunologic responses acquired during life but notpresent at birth
y Usually develops as a result of prior exposure toantigen through immunization (vaccination) or bycontracting a disease, both of which generate aprotective immune response.
8/8/2019 Inflammation & Immunity Final Final Final (7)
8/53
Types of acquired immunityActiveAcquired Immunity
yNatural Acquired Immunity- Immunity that is acquired
in response to the entry of a live pathogen into thebody.
yActual Acquired Immunity- It is the immunity that isacquired in response to vaccine
8/8/2019 Inflammation & Immunity Final Final Final (7)
9/53
PassiveAcquired Immunity
y Natural Passive Acquired Immunity- Temporaryimmunity transmitted from another source that has
developed immunity through previous
disea
se orimmunization.
y Artificial passive Acquired Immunity- Immunitythat is acquired when a person receives antibodies
contained in antisera or gamma globulin
8/8/2019 Inflammation & Immunity Final Final Final (7)
10/53
Types of Hypersensitivity
ReactionsHypersensitivity
y Refers to the excessive, undesirable (damaging,discomfort-producing and sometimes fatal) reactionsproduced by the immune system.
y Reaction require pre-sensitized (immune) state of thehost
y Reactions can be divided into four (4) types:Type I,
Type II, Type III and Type IV, based on themechanisms involved and time taken for the reaction.
y Frequently, particular clinical condition (disease) mayinvolve more than one type of reaction
8/8/2019 Inflammation & Immunity Final Final Final (7)
11/53
Type I Hypersensitivity
y Also known as immediate or anaphylactichypersensitivity
y Reaction may involve skin (uticaria and eczema), eyes
(conjunctivitis), nasopharynx (rhinorrhea, rhinitis),bronchopulmonary tissues (asthma) andgastrointestinal tract (gastroenteritis).
y The reaction may cause a range ofsymptoms from
minor inconvenience to death.y The reaction usually takes 15-30 minutes from the time
of exposure to the antigen, although sometimes it maybe a delayed onset (10-12 hours)
8/8/2019 Inflammation & Immunity Final Final Final (7)
12/53
y Immediate sensitivity is mediated byIg E
y Cellular component in this hypersensitivity is the mastcell or basophils.
y Reaction is amplified and or modified by platelets,neutrophils and eosinophils.
y Abiopsy of the reaction site demonstrates mainly mastcells and eosinophils.
8/8/2019 Inflammation & Immunity Final Final Final (7)
13/53
Type II Hypersensitivity
y Also known as Cytotoxic Hypersensitivity and mayaffectvariety of organs and tissues.
yThe antigens are normally endogenous, althoughexogenous chemical (haptens) which can attach to thecell membranes can also lead to type IIhypersensitivity.
yDrug-induced hemolytic anemia, glaucoma andthrombocytopenia are such examples.
8/8/2019 Inflammation & Immunity Final Final Final (7)
14/53
y The reaction time is minutes to hours.
y Type II hypersensitivity is primarily mediated byantibodies of the Ig M or Ig G classes and complementPhagocytes and K cells may also play a role.
y Lesions contains antibody, complement and
neutrophils.
y Diagnostics test include detection of circulatingantibodies against the tissues involved and the presenceof antibody and complement in the lesion (biopsy) by
immunofluorescence.
y Treatment involves anti-inflammatory andimmunosuppressive agents.
8/8/2019 Inflammation & Immunity Final Final Final (7)
15/53
Type III Hypersensitivityy Also known asImmune Complex Hypersensitivity
y The reaction may take up to 3 10 hours after
exposure to the antigeny They are most of the IgG class, although IgM may also
involved
y Example given systemic Lupus Erythematous, SLE
8/8/2019 Inflammation & Immunity Final Final Final (7)
16/53
Type IV Hypersensitivityy Also known as cell mediated or delayed type
hypersensitivity
yThe classical example is tubercullin ( Montoux )reaction 48 hours after the injection of antigen ( PPDor old tubercullin )
y Involved in the pathogenesis of many autoimmune
and infectious diseases ( tuberculosis, leprosy,blastomycosis, histoplasmosis and toxoplasmosis ) andgranulomasdue to infection and foreign antigens
8/8/2019 Inflammation & Immunity Final Final Final (7)
17/53
Comparison of Different Types of
Hypersensitivity
Characteristics Type-I
(Anaphylactic)
Type II (Cytotoxic) Type III
( Immune Complex)
Type-IV
(delayed type )
Antibody IgE IgG, IgM IgG, IgM T cells
Antigen Exogenous Cell surface Soluble Tissues & organs
Response time 15 -30 minutes Minutes hours 3-8 hours 48 72 hours
Appearance Weal & flare Lysis and necrosis Erythema and edema,
necrosis
Erythema and
induration
Histology Basophils and
eosinophils
Antibody and
complement
Complement and
neutrophils
Monocytes and
lymphocytes
Transferred with Antibody Antibody Antibody T cells
Examples Allergic, asthma, hay
fever
Erythroblastosis
Fetalis,
Goodpastures
Nephritis
SLE, farmers lung
disease
Tubercullin test,
poison Ivy and
granuloma
8/8/2019 Inflammation & Immunity Final Final Final (7)
18/53
Terminologies
Immunocompetent
y If the persons immune system is functioning properly,that person issaid to be an immunocompetent person.
8/8/2019 Inflammation & Immunity Final Final Final (7)
19/53
TerminologiesImmunodefficiency
y Occurs as a result of deficiencies in antibody
production, complement activity and phagocyticfunction.
y Hereditary disease (agammaglobulinemia,hypogammaglobulinemia, chronic granulomatosus
disease and Chediak-Higasi syndrome)
8/8/2019 Inflammation & Immunity Final Final Final (7)
20/53
TerminologiesImmunosupression
y Immunosuppression may result from certain diseasessuchas AIDS or lymphoma or from certain drugssuch assome
of those used to treat cancer.y It may also be deliberately induced with drugs, as in
preparation for bone marrow orother organ transplantation to prevent the rejection ofthe transplant.
Immunosuppressive drugs :
y glucocorticoids, cytostatics, antibodies, drugs acting onimmunophilins
8/8/2019 Inflammation & Immunity Final Final Final (7)
21/53
TerminologiesAutoimmune Diseasesy Results when a persons immune system no longer
recognizes certain body tissues asself, and attempts to
destroy those tissues as if they were oneself or foreign.y Examples include:y rheumatoid arthritis,y multiple sclerosis,y myasthenia gravis,y systemic lupus erythematosusy Crohn's diseasey pemphigusy ulcerative colitis
8/8/2019 Inflammation & Immunity Final Final Final (7)
22/53
TerminologiesVaccine
y Is defined as material that can artificially induce
immunity to an infectious disease, usually afterinjection or, in some cases ingestion of the material(i.e., oral polio vaccine).
y Vaccines are made from living or dead (inactivated)
pathogens or from certain toxins they produce.
8/8/2019 Inflammation & Immunity Final Final Final (7)
23/53
TerminologiesAntigens
y Substances capable ofstimulating response from theimmune system.
Antibodies or Immunoglobulin
y Proteins created in response to specific antigen.
y
Immunoglobulin plays an essential role in the body'simmune system.
y They attach to foreign substances, such as bacteria,and assist in destroying them.
8/8/2019 Inflammation & Immunity Final Final Final (7)
24/53
CLASSES OF IMMUNOGLOBULINS
Immunoglobulin A (Ig A) The most predominant class, found in saliva,
seminal fluid, colostrums, breast milk and
mucous secretion of the nose, lungs and
gastro intestinal tract.
Immunoglobulin D (Ig D) Found in large quantities on the surface of B
cells
Immunoglobulin E (Ig E) Ig E is produced in response to allergens.
Found on the surfaces of basophils and mass
cells. Plays a major role in allergic responses.
8/8/2019 Inflammation & Immunity Final Final Final (7)
25/53
CLASSES OF IMMUNOGLOBULINS
Immunoglobulin G (Ig G) The only class of immunoglobulin
that can cross the placenta.
Maternal Ig G that crosses the
placenta help protect the newborn
during its first months of life.
Immunoglobulin M (Ig M) Most abundant circulatory
antibodies.
First Ab formed in the primary
response to antigens. It provides
protection in the earliest stage of
infection
8/8/2019 Inflammation & Immunity Final Final Final (7)
26/53
xpan e r gram r
Immunizati n (EPI)
Objective:
y To reduce the infant mortality and morbidity ratethrough decreasing the prevalence of 6 vaccines
preventable diseases.Preventable Diseases
y Tuberculosisy Diphtheriay
Pertussisy Tetanusy Polioy Measles
8/8/2019 Inflammation & Immunity Final Final Final (7)
27/53
Vaccine Min Age at
1st
ose
No. of
oses
ose Minimum
Interval
Route Site Reason
Bacillus
Calmette-
Guerin
Birth or
anytime
after birth
1 0.05 ml --- Intradermal Rt.
eltoid
region of the
arm
BCG given the
earliest possible age,
protects the
possibility of TB
meningitis and other
TB infections in
which infants are
prone.
PT 6 weeks 3 0.5 ml 4 weeks Intramuscular Upper outer
portion of the
thigh
An early start with
PT reduces the
chance of severe
pertussis.
8/8/2019 Inflammation & Immunity Final Final Final (7)
28/53
Oral Polio
Vaccine
6 weeks 3 2-3 drops 4 weeks Oral Mouth The extent of
protection against
polio is increased the
earlier the OPV is
given.
Hep B Vaccine At birth 3 0.5ml 6 wks
interval from
1stdose to
2nd
dose, 8wks interval
from 2nd
dose to 3rd
dose
Intramuscular Upper outer
portion of the
thigh
The early start of
Hepatitis B vaccine
reduces the chance
of being infected andbecoming a carrier.
Prevents liver
cirrhosis and liver
cancer which are
likely to develop if
infected with Hep Bearly in life.
MeaslesVaccine 9 months 1 0.5 ml --- Subcutaneous Upper outer
portion of the
arms
At least 85% of
measles can be
prevented by
immunization at this
age.
8/8/2019 Inflammation & Immunity Final Final Final (7)
29/53
Tetanus Toxoid Immunization Scheduled for
Women
When given to women of childbearing age, vaccinesthat contain tetanus toxoid, may not only protect
women against tetanu
s, but al
so prevent neonataltetanus in newborn infant.
8/8/2019 Inflammation & Immunity Final Final Final (7)
30/53
Vaccines Minimum Age/Interval Percent
Protected
uration of Protection
TT1 As early as possible
during pregnancy
--- ---
TT2 At least 4 weeks later 80% Infants born to the mother will be protected
from neonatal tetanus, give 5 years
protection for the mother
TT3 At least 6 months later 95% Infants born to the mother will be protected
from neonatal tetanus, give 5 years
protection for the mother
TT4 At least 1 year later 99% Infants born to the mother will be protected
from neonatal tetanus, give 10 yearsprotection for the mother
TT5 At least 1 year later 99% Gives life time for the mother.
All infants born to the mother will be
protected.
8/8/2019 Inflammation & Immunity Final Final Final (7)
31/53
Universal recautions of Immunization
yHand washing after any direct contact with patients
yPreventing two-handed recapping of needles
y Safe collection and disposal of needles (hypodermic andsuture) and sharps (scalpel blades, lancets, razors, scissors),with required puncture- and liquid- proof safety boxes ineach patient care area
yWearing gloves for contact with body fluids, non-intact skin
and mucous membranes
8/8/2019 Inflammation & Immunity Final Final Final (7)
32/53
Universal recautions of Immunization
yWearing a mask, eye protection and a gown (and sometimes aplastic apron) if blood or other body fluids might splash
y Covering all cuts and abrasions with a waterproof dressing
yPromptly and carefullycleaning up spills of blood and otherbody fluids
y
Using a safe system for health care waste management anddisposal
8/8/2019 Inflammation & Immunity Final Final Final (7)
33/53
Group 2
8/8/2019 Inflammation & Immunity Final Final Final (7)
34/53
Inflammation
y Adefensive reaction intended to neutralize, control oreliminate the offending agent and to prepare the sitefor repair.
y Redness, swelling, pain, and/or a feeling of heat in anarea of the body are protective reactions to injury,disease, or irritation of the tissues.
8/8/2019 Inflammation & Immunity Final Final Final (7)
35/53
Types of Inflammationy Acute Inflammation
y Chronic Inflammation
y Subacute Inflammationy CellularHealing
Regeneration
Replacement
8/8/2019 Inflammation & Immunity Final Final Final (7)
36/53
Types of InflammationAcute Inflammation
y Is characterized by the local vascular and exudative
changes
and usually la
sts
less
than 2 weeks.
y Immediate and serves as a protective function
y After the causative again is removed, the inflammationsubsides and healing takes place with the return of
normal or nearly normal structure and function.
8/8/2019 Inflammation & Immunity Final Final Final (7)
37/53
Chronic Inflammation
y Develops if the injurious agent persists and the acuteresponse is perpetuated
y Symptoms are present for many months or yearsy May begin insidiously and never have an acute phase
y As the inflammation becomes chronic, changes occur atthe site of injury and the nature of exudates becomes
proliferative.
8/8/2019 Inflammation & Immunity Final Final Final (7)
38/53
Chronic Inflammation (cont.)
y Acycle of cellular infiltration, necrosis and fibrosis
begins with repair and breakdown occurringsimultaneously.
y Considerablyscarring may occur, resulting inpermanent tissue damage
8/8/2019 Inflammation & Immunity Final Final Final (7)
39/53
y Subacute inflammation falls between acute andchronic inflammation
y
It includes elements of the active exudative phase ofthe acute response as well as the elements of repair, asin the chronic phase.
Subacute Inflammation
8/8/2019 Inflammation & Immunity Final Final Final (7)
40/53
8/8/2019 Inflammation & Immunity Final Final Final (7)
41/53
CellularHealing (cont.)
y It may occur by regeneration, in which gradual repairof the defects occur by proliferation of cells of thesame types as those destroyed or by replacement, in
which cells of another type, usually connective tissue,
fill in the tissue defect and result in scar formation.
8/8/2019 Inflammation & Immunity Final Final Final (7)
42/53
Regeneration
y The ability of the cells to regenerate depends onwhether they are labile, permanent or stable
y Labile cells multiple constantly to replace cell worn
out by normal physiologic proce
sses;
8/8/2019 Inflammation & Immunity Final Final Final (7)
43/53
Replacement
y The condition of the host, the environment and thenature and severity of the injury affect the process ofthe inflammation, repair and replacement.
y Depending on the extent of damage, repair and
replacement may occur by first, second or thirdintention healing.
8/8/2019 Inflammation & Immunity Final Final Final (7)
44/53
CLASSIFICATION OF HEALING
First Intention Healing Second Intention Healing Third Intention Healing
Wound edges are
approximated
Little scar formation
occurs and the wound
healing occurs without
granulation.
Occurs in clean cut wound
The edges are not
approximated and the
wound fills with
granulation tissue.
Occurs when the wound
is extensive and there is a
great amount of tissue
loss.
The process of repair
takes longer and may
result in scar formation,
with loss of specialized
function.
Ex. People who have
recovered from MI.
Wound edges are
approximated and healing
is delayed
Occurs when there is a
delayed surgical closure of
infective wound
8/8/2019 Inflammation & Immunity Final Final Final (7)
45/53
Stages of Inflammation
8/8/2019 Inflammation & Immunity Final Final Final (7)
46/53
Incubation
y The time between the exposure to an infectiousdisease and its development.
y This period may last from a few minutes to a few days,weeks, months or even years.
y During thisstage morbid matter, poisons,microorganisms and other excitants of inflammationgather and concentrate in certain parts and organs ofthe body.
8/8/2019 Inflammation & Immunity Final Final Final (7)
47/53
Aggravation
y The battle between the phagocytes and Nature'santitoxins on the one hand, and the poisons andmicroorganismsof disease on the other hand,
gradually progress
es, accompanied by a corre
spondingincrease of fever and inflammation, until it reaches its
climax, marked by the greatest intensity of feverishsymptoms.
8/8/2019 Inflammation & Immunity Final Final Final (7)
48/53
Destruction
y This battle between the forces of disease and thehealing forces is accompanied by the disintegration oftissues due to the accumulation of exudates, to pus
formation, the development of abscesses, boils,fistulas, open sores, etc., and to other morbid changes.
y Thisstage ends in crisis, which may be either fatal orbeneficial.
8/8/2019 Inflammation & Immunity Final Final Final (7)
49/53
Abatement
y The absorption and elimination of exudates, pus, etc.,take place during the period of abatement.
y It is accompanied by a gradual lowering of
temperature, pulse rate and the other symptoms offever and inflammation.
8/8/2019 Inflammation & Immunity Final Final Final (7)
50/53
Resolution orReconstruction
y The work of rebuilding the injured parts and organsbegins. More or less destruction has taken place in thecells and tissues, the blood vessels and organs of theareas involved.
y These must now be reconstructed, and this last stageof the inflammatory process is, therefore, in a way themost important.
8/8/2019 Inflammation & Immunity Final Final Final (7)
51/53
Universal precautions of inflammation
The first step in getting pain under control is to change yourdiet.
y Sugar and simple carbohydrates are known to fire upinflammation.
y Eliminate as many of these as possible.
The second step is to get an adequate amount ofsleep.
y Afull night sleep is not a luxury, it is a necessity.y Our bodies repair during sleep, and sleep deprivation has
been shown to markedly increase inflammation.y One studyshowed a fifty to sixty percent increase in pro-
inflammatorysubstances during times of inadequate sleep.
8/8/2019 Inflammation & Immunity Final Final Final (7)
52/53
The third step is to exercise.
y Exercise suppresses inflammation.
y Gentle walking and stretching is beneficial even to thosewith chronic conditions who otherwise have trouble beingactive.
The forth step is to control your blood sugar levels.
y Insulin is a factor in chronic inflammation.y Choose foods that are low on the glycemic index. (This is a
measurement of how quickly a food causes blood sugarspikes.)
The fifth step is to keep your weight at a healthy level.
y Excess body fat produces pro-inflammatorysubstances, aswell as putting stress on your joints.
8/8/2019 Inflammation & Immunity Final Final Final (7)
53/53
The last step is to consider taking supplements that areknown to reduce inflammation.
y Fatty acids from fish oil interrupt the production ofpro-inflammatorysubstances in the body.
y Other supplements to research are DHEA, vitamin Eand turmeric.All of these have anti-inflammatoryproperties.